Top Markets
#1 Decred Decred +10.19%
#2 Wibx Wibx +9.06%
#3 Status Status +7.37%
#4 aelf aelf +5.49%
#5 SkyAI SkyAI +4.75%
#6 MarsCoin MarsCoin +4.32%
#7 Rei Rei +4.03%
#8 Robinhood Wrapped ETH (Robinhood Chain) Robinhood Wrapped ETH (Robinhood Chain) +3.86%
#9 TRIA TRIA +3.71%
#10 Humanity Humanity +3.23%
Coin of the day
Decred Decred
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Finch Therapeutics Group, Inc. Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc.

FNCH
Clasificación en acciones #30543
Finch Therapeutics is a microbiome technology company with a portfolio of... Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down development efforts.
Precio por acción
$10.20
Última sincronización: 2026-08-05
Capitalización bursátil
$16.38M
Cambio (1 día)
2.00%
Cambio (1 año)
-18.40%
País
US
Comercio Finch Therapeutics Group, Inc. (FNCH)

Categoría

Healthcare
Ratio P/B de Finch Therapeutics Group, Inc. (FNCH)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Finch Therapeutics Group, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Finch Therapeutics Group, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE